Surgery Partners EBITDA Margin 2013-2025 | SGRY
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Surgery Partners (SGRY) over the last 10 years. The current EBITDA margin for Surgery Partners as of September 30, 2025 is .
| Surgery Partners EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-09-30 | $3.29B | $0.58B | 17.64% |
| 2025-06-30 | $3.24B | $0.55B | 16.87% |
| 2025-03-31 | $3.17B | $0.51B | 16.14% |
| 2024-12-31 | $3.11B | $0.52B | 16.70% |
| 2024-09-30 | $2.98B | $0.49B | 16.39% |
| 2024-06-30 | $2.89B | $0.49B | 16.90% |
| 2024-03-31 | $2.79B | $0.49B | 17.50% |
| 2023-12-31 | $2.74B | $0.46B | 16.77% |
| 2023-09-30 | $2.72B | $0.45B | 16.61% |
| 2023-06-30 | $2.66B | $0.44B | 16.60% |
| 2023-03-31 | $2.61B | $0.42B | 16.25% |
| 2022-12-31 | $2.54B | $0.47B | 18.59% |
| 2022-09-30 | $2.44B | $0.48B | 19.82% |
| 2022-06-30 | $2.38B | $0.47B | 19.75% |
| 2022-03-31 | $2.31B | $0.45B | 19.54% |
| 2021-12-31 | $2.22B | $0.41B | 18.57% |
| 2021-09-30 | $2.16B | $0.40B | 18.41% |
| 2021-06-30 | $2.10B | $0.35B | 16.77% |
| 2021-03-31 | $1.93B | $0.34B | 17.35% |
| 2020-12-31 | $1.86B | $0.29B | 15.54% |
| 2020-09-30 | $1.83B | $0.26B | 14.22% |
| 2020-06-30 | $1.79B | $0.29B | 16.47% |
| 2020-03-31 | $1.86B | $0.30B | 16.17% |
| 2019-12-31 | $1.83B | $0.32B | 17.64% |
| 2019-09-30 | $1.81B | $0.20B | 10.86% |
| 2019-06-30 | $1.79B | $0.18B | 10.08% |
| 2019-03-31 | $1.78B | $0.17B | 9.34% |
| 2018-12-31 | $1.77B | $0.16B | 8.75% |
| 2018-09-30 | $1.74B | $0.29B | 16.49% |
| 2018-06-30 | $1.61B | $0.23B | 14.50% |
| 2018-03-31 | $1.47B | $0.22B | 14.95% |
| 2017-12-31 | $1.34B | $0.22B | 16.12% |
| 2017-09-30 | $1.19B | $0.19B | 16.10% |
| 2017-06-30 | $1.16B | $0.24B | 20.29% |
| 2017-03-31 | $1.17B | $0.25B | 21.63% |
| 2016-12-31 | $1.15B | $0.24B | 21.12% |
| 2016-09-30 | $1.10B | $0.20B | 17.95% |
| 2016-06-30 | $1.06B | $0.20B | 18.68% |
| 2016-03-31 | $1.00B | $0.19B | 18.54% |
| 2015-12-31 | $0.96B | $0.19B | 19.69% |
| 2015-06-30 | $0.53B | $0.12B | 22.70% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $1.754B | $3.114B |
| Surgery Partners, Inc. is a healthcare services company. The Company's outpatient delivery model focused on providing solutions for surgical and related ancillary care in support of its patients and physicians. Its operating segment consists of Surgical Facility Services segment, Ancillary Services segment and Optical Services segment. Surgery Partners, Inc. is based in Nashville, Tennessee. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $153.002B | 27.77 |
| HCA Healthcare (HCA) | United States | $114.483B | 17.75 |
| CVS Health (CVS) | United States | $99.460B | 11.44 |
| Elevance Health (ELV) | United States | $75.335B | 11.24 |
| Cencora (COR) | United States | $69.692B | 21.99 |
| Natera (NTRA) | United States | $28.085B | 0.00 |
| DiDi Global (DIDIY) | China | $23.132B | 21.37 |
| Labcorp Holdings (LH) | United States | $22.980B | 17.52 |
| Viatris (VTRS) | United States | $16.793B | 6.26 |
| Medpace Holdings (MEDP) | United States | $15.268B | 37.90 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.244B | 0.00 |
| Solventum (SOLV) | United States | $13.550B | 13.15 |
| BioMerieux (BMXMF) | France | $13.324B | 0.00 |
| ICON (ICLR) | Ireland | $12.161B | 12.07 |
| CochLear (CHEOY) | Australia | $11.774B | 0.00 |
| Revvity (RVTY) | United States | $11.518B | 20.04 |
| Charles River Laboratories (CRL) | United States | $9.312B | 17.93 |
| Sonic Healthcare (SKHHY) | Australia | $7.878B | 0.00 |
| Avantor (AVTR) | United States | $7.677B | 11.73 |
| BrightSpring Health Services (BTSG) | United States | $7.156B | 42.67 |
| HealthEquity (HQY) | United States | $6.788B | 25.38 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.207B | 0.00 |
| PACS (PACS) | United States | $6.058B | 36.84 |
| Bausch + Lomb (BLCO) | Canada | $6.022B | 39.53 |
| Sotera Health (SHC) | United States | $5.043B | 24.32 |
| Alignment Healthcare (ALHC) | United States | $4.352B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.532B | 20.61 |
| Concentras Parent (CON) | United States | $3.012B | 18.80 |
| GeneDx Holdings (WGS) | United States | $2.436B | 42.79 |
| Organon (OGN) | United States | $2.134B | 2.25 |
| Establishment Labs Holdings (ESTA) | United States | $1.999B | 0.00 |
| Progyny (PGNY) | United States | $1.892B | 37.20 |
| Pediatrix Medical (MD) | United States | $1.794B | 10.71 |
| Ardent Health (ARDT) | United States | $1.280B | 4.18 |
| InnovAge Holding (INNV) | United States | $1.134B | 167.20 |
| CareDx (CDNA) | United States | $1.001B | 16.36 |
| Teladoc Health (TDOC) | United States | $0.889B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.828B | 13.56 |
| Nutex Health (NUTX) | United States | $0.706B | 5.40 |
| Omada Health (OMDA) | United States | $0.675B | 0.00 |
| Embecta (EMBC) | United States | $0.643B | 3.59 |
| Sonida Senior Living (SNDA) | United States | $0.642B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.594B | 0.00 |
| Enhabit (EHAB) | United States | $0.563B | 25.30 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| SBC Medicals (SBC) | United States | $0.466B | 8.57 |
| CryoPort (CYRX) | United States | $0.437B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.409B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.391B | 82.38 |
| Auna S.A (AUNA) | Luxembourg | $0.352B | 5.67 |
| So-Young (SY) | China | $0.339B | 0.00 |
| Agilon Health (AGL) | United States | $0.269B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.262B | 0.00 |
| Oncology Institute (TOI) | United States | $0.257B | 0.00 |
| Beauty Health (SKIN) | United States | $0.163B | 0.00 |
| LifeMD (LFMD) | United States | $0.151B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.134B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.097B | 0.00 |
| Biodesix (BDSX) | United States | $0.083B | 0.00 |
| DocGo (DCGO) | United States | $0.076B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.070B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.041B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.039B | 0.00 |
| Pomdoctor - (POM) | China | $0.023B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 6.10 |
| OSR Holdings (OSRH) | United States | $0.014B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.012B | 0.00 |
| Lifeward (LFWD) | United States | $0.010B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |